实际的新型致癌肼类、酰肼类和腙类化合物。
Actual new cancer-causing hydrazines, hydrazides, and hydrazones.
作者信息
Toth B
出版信息
J Cancer Res Clin Oncol. 1980;97(2):97-108. doi: 10.1007/BF00409895.
Abstract
Twenty actual new cancer-causing hydrazines, hydrazides, and hydrazones of synthetic or natural origin are described. These compounds induce tumors in various target tissues in mice, hamsters and rats. To nine of these compounds the human population is exposed in the form of drugs, agricultural herbicides, and naturally occurring ingredients of edible mushrooms. Yet, with one exception, none of the hydrazines described here were investigated for cancer-inducing abilities in man. The human population should be warned against the use of this hazardous class of chemicals, the total number of which is now 40.
摘要
本文描述了20种实际存在的、具有致癌性的肼类、酰肼类和腙类化合物，它们或是合成的，或是天然存在的。这些化合物能在小鼠、仓鼠和大鼠的各种靶组织中诱发肿瘤。人类以药物、农用除草剂以及可食用蘑菇中的天然成分等形式接触到其中的9种化合物。然而，除了一种例外情况，本文所述的肼类化合物均未针对其对人类的致癌能力进行研究。应警告人类不要使用这类危险化学品，目前这类化学品的总数为40种。
相似文献
1
Actual new cancer-causing hydrazines, hydrazides, and hydrazones.
J Cancer Res Clin Oncol. 1980;97(2):97-108. doi: 10.1007/BF00409895.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
4
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.
Cochrane Database Syst Rev. 2016 Apr 19;4:CD011621. doi: 10.1002/14651858.CD011621.pub2.
5
Hydrazides as Powerful Tools in Medicinal Chemistry: Synthesis, Reactivity, and Biological Applications.
Molecules. 2025 Jul 3;30(13):2852. doi: 10.3390/molecules30132852.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
8
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
10
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
引用本文的文献
1
Hemipiperazines as peptide-derived molecular photoswitches with low-nanomolar cytotoxicity.
Nat Commun. 2022 Oct 14;13(1):6066. doi: 10.1038/s41467-022-33750-7.
2
BIOTRANSFORMATION OF HYDRAZINE DERVATIVES IN THE MECHANISM OF TOXICITY.
J Drug Metab Toxicol. 2014;5(3). doi: 10.4172/2157-7609.1000168. Epub 2014 Jul 8.
3
The mutagenic mechanism of oxygenated alkylhydrazones occurs through alkyl radicals and alkyldiazonium ions.
Toxicol Res (Camb). 2017 Feb 2;6(2):173-178. doi: 10.1039/c6tx00430j. eCollection 2017 Mar 1.
4
DNA cleavage and detection of DNA radicals formed from hydralazine and copper (II) by ESR and immuno-spin trapping.
Chem Res Toxicol. 2014 Apr 21;27(4):674-82. doi: 10.1021/tx500011m. Epub 2014 Feb 13.
5
Tumorigenesis by N-n-propyl-N-formylhydrazine in mice.
Br J Cancer. 1980 Dec;42(6):922-8. doi: 10.1038/bjc.1980.341.
6
1,2-di-n-butylhydrazine dihydrochloride carcinogenesis in mice.
Experientia. 1981 Jul 15;37(7):773-5. doi: 10.1007/BF01967972.
7
Tumorigenicity of minute dose levels of N-methyl-N-formylhydrazine of Gyromitra esculenta.
Mycopathologia. 1982 Apr 23;78(1):11-6. doi: 10.1007/BF00436576.
8
Carcinogenicity study in mice on pildralazine, a hydralazinelike antihypertensive compound.
J Cancer Res Clin Oncol. 1983;106(2):97-101. doi: 10.1007/BF00395386.
9
Mutagenic and genotoxic activities of extracts derived from the cooked and raw edible mushroom Agaricus bisporus.
J Cancer Res Clin Oncol. 1990;116(5):475-9. doi: 10.1007/BF01612997.
本文引用的文献
1
Nitrogen fixation research: a key to world food?
Science. 1975 May 9;188(4188):633-43. doi: 10.1126/science.188.4188.633.
2
ISOLATION AND STRUCTURE OF AGARITINE, A GAMMA-GLUTAMYL-SUBSTITUTED ARYLHYDRAZINE DERIVATIVE FROM AGARICACEAE.
J Biol Chem. 1964 Jul;239:2267-73.
3
[Experimental studies on the carcinogenic effects of isonicotinic acid hydrazide (INH)].
Tuberkulozis. 1957 Mar-Apr;10(3-4):49-54.
4
Isoniazid therapy in relation to later occurrence of cancer in adults and in infants.
Br Med J. 1967 Jun 24;2(5555):792-5. doi: 10.1136/bmj.2.5555.792.
5
Carcinogenesis in Swiss mice by isonicotinic acid hydrazide.
Cancer Res. 1966 Jul;26(7):1473-5.
6
Hepatic carcinogenesis in CBA-Cb-Se mice and Cb-Se rats by isonicotinic acid hydrazide and hydrazine sulfate.
J Natl Cancer Inst. 1968 Aug;41(2):331-49.
7
A new antibiotic, negamycin.
J Antibiot (Tokyo). 1970 Mar;23(3):170-1. doi: 10.7164/antibiotics.23.170.
8
9
The carcinogenic activity of some 5-nitrofuran derivatives in the rat.
Cancer Res. 1969 Dec;29(12):2145-56.
10
[Detection and content determination of gyromitrin in fresh Gyromitra esculenta. 19. Mushroom contents].
Arch Pharm Ber Dtsch Pharm Ges. 1969 Feb;302(2):143-6. doi: 10.1002/ardp.19693020209.
Zotero 插件